Neoplasia/BPH

	Development and Validation of Predictive Models for Trifecta Achievement in Robot-Assisted Partial Nephrectomy for Renal Hilar Tumors: Preliminary Application of the Modified R.E.N.A.L. Score. J Endourol Yuan Y, Zhou L, Yang J, Zheng F, Zou X, Liu X, Chen L, Hu J, Fu B. PMID: 41693513 [PubMed - indexed for MEDLINE]
	Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: Current Evidence and Future Directions. Int J Urol Takahara K, Takeuchi A, Saruta M, Yoshizawa A, Nukaya T, Takenaka M, Ichino M, Sasaki H. PMID: 41692947 [PubMed - indexed for MEDLINE]
	Metabolism in Tumour-Induced Bone Disease. Curr Osteoporos Rep Ormsby RT, Edwards CM. PMID: 41692878 [PubMed - indexed for MEDLINE]
	Automated Classification of Kidney Tumours Using Deep Convolutional Neural Networks. Int J Med Robot Guo M, Lin S, You Y, Wei L. PMID: 41691614 [PubMed - indexed for MEDLINE]
	Association between baseline prostate MRI PI-RADS classification and risk of Gleason upgrade during active surveillance: a systematic review and meta-analysis. World J Urol Smani S, Sohoni N, Miszczyk M, Fazekas T, Rajwa P, Grimshaw AA, Sundaresan VM, Lokeshwar SD, Weinreb J, Sprenkle PC, Cooperberg MR, Seibert TM, Shariat SF, Catalona WJ, Leapman MS. PMID: 41691567 [PubMed - indexed for MEDLINE]
	Occupational Exposure to Welding Fumes and the Risk of Bladder Cancer: A Systematic Review and Meta-Analysis. Am J Ind Med Ryoo SW, Choi BY, Son SY, Lee JH, Kang MY. PMID: 41691436 [PubMed - as supplied by publisher]
	Interpretable habitat and peritumoral radiomics from multiparametric MRI for preoperative high-risk prostate cancer prediction: a multi-institutional study. J Transl Med Yuan M, Chang D, Lu W, Ma K, Gu Y, Xia T, Peng J, Zhang Y, Fu L, Zhao B. PMID: 41691237 [PubMed - as supplied by publisher]
	Prognostic value of the prognostic nutritional index for patients with renal cell carcinoma: an update systematic review and meta-analysis. BMC Cancer Xu Z, Xie L, Zhang H, Han G, Guo W. PMID: 41691234 [PubMed - as supplied by publisher]
	Spatiotemporal patterns and clustering of prostate cancer incidence in China: a Bayesian modeling study of cancer registry data. BMC Public Health Zhu X, Chen Z, Ge MW, Rehman AU, Chen HL, Zhu H, Zheng B. PMID: 41691228 [PubMed - as supplied by publisher]
	Surgery or Radiotherapy: Determining Factors in Therapeutic Decision-Making for Localized Prostate Cancer in Spain. Actas Urol Esp (Engl Ed) Perez-Ardavin J, Vera-Donoso CD, Alapont JM, Martinez-Sarmiento M, Monserrat JJ, Ruíz Cerdá JL, Conde AJ, Budía Alba A. PMID: 41690467 [PubMed - as supplied by publisher]
	Bladder and rectal cancer development in prostate cancer patients treated with surgery or radiotherapy: A population-based study. Actas Urol Esp (Engl Ed) Martínez Rodríguez P, Poza Fernandez A, García Fadrique G, Acedo González J, Montero Adriá O, Mateo Cárcel N, Marzullo Zucchet L, Gómez Palomo F, Reig Ruiz C. PMID: 41690466 [PubMed - as supplied by publisher]
	Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial. Radiother Oncol Michalet M, Ronchin P, Reynaud T, Demogeot N, Gourgou S, Thézenas S, Hannoun-Lévi JM, Salem N, Quivrin M, Riou O, Charissoux M, Llacer-Moscardo C, Tosi D, Durdux C, Khalladi N, Culine S, Azria D. PMID: 41690405 [PubMed - as supplied by publisher]
	Optimal adjuvant intravesical therapy for intermediate risk non-muscle invasive bladder cancer; oncological and patient-reported outcomes of randomized controlled trial. Urol Oncol Elsawy AA, Laymon M, Ezzat O, Mansour I, Sobh AA, Nour EA, Mosbah A. PMID: 41689868 [PubMed - as supplied by publisher]
	MiRNA based liquid biopsy for castration-resistant prostate cancer diagnostics. Mol Cell Biochem Konoshenko MY, Saitkulova MM, Shutko EV, Ostaltsev IA, Laktionov PP, Bryzgunova OE. PMID: 41689709 [PubMed - as supplied by publisher]
	Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives. Discov Oncol Giunta EF, Schepisi G, Bleve S, Serra R, Brighi N, Torresan I, Tassinari E, Zanuccoli S, Lolli C. PMID: 41689691 [PubMed - as supplied by publisher]
	Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25. Cancer Immunol Immunother Roviello G, Gambale E, De Gennaro Aquino I, Maruzzo M, Messina C, Vascotto IA, Rossi V, Bimbatti D, Erbetta E, Messina M, Mennitto A, Rebuzzi SE, Nasso C, Mercinelli C, Catalano M, Maiorano BA, Fanelli M, Sorarù M, Scolari F, Mela MM, Galli L, Salfi A, Rizzo M, Puglisi S, Orlando V, Fornarini G, Rametta A, Giannatempo P, Cerbone L, Doni L, Pillozzi S, Antonuzzo L. PMID: 41689638 [PubMed - indexed for MEDLINE]
	Pharmacokinetics and Dosimetry of [(68)Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study. Cancer Biother Radiopharm Fan W, Li Y, Shi H, Guo J, Huang R, Dong Q, Yang Z, Yang Y, Wang X, Gu D, Ye D, Wang F, Wang J, Xu D, Jiang Z, Li H, Li J, Li R, Huo L, Ji Z. PMID: 41689461 [PubMed - as supplied by publisher]
	The Modified Frailty Index-5 as a Predictor of Postoperative Complications Following Radical Cystectomy. J Coll Physicians Surg Pak Dincer E, Ozkaptan O, Canakci C, Ipek OM, Coskun A, Can U. PMID: 41689329 [PubMed - indexed for MEDLINE]
	Magnetic resonance-guided simultaneous multi-foâ€‹cal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study. Radiat Oncol Sun M, Qin SR, Wei R, Tian Y, Yan LL, Xia WL, Liu ZQ, Fu Q, Song YW, Fang H, Jing H, Wang SL, Li YX, Xing NZ, Lu NN. PMID: 41689033 [PubMed - as supplied by publisher]
	Is transurethral enucleation of the prostate combined with internal incision of peripheral zone abscesses a safe treatment for prostate multilocular abscesses? Aging Male Du J, Yuan X, Wang Y, Wang K, Wang L, Zhou H, Yu Z, Ren A, Lun X, Liu W, Shen T, Bi Y, Han B. PMID: 41688873 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 185496

Page 1 of 9275



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy